Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;117(4):884-886.
doi: 10.1002/cpt.3596. Epub 2025 Feb 14.

Clinical Evidence 2030

Peter Arlett  1 , Denise Umuhire  1 , Patrice Verpillat  1 , Paolo Foggi  2 , Ulla Wändel Liminga  3 , Bruno Sepodes  4 , Marianne Lunzer  5 , Brian Aylward  6 , Spiros Vamvakas  1 , Kit Roes  7 , Frank Pétavy  1 , Steffen Thirstrup  1 , Maria Lamas  8 , Emer Cooke  1 , Karl Broich  9
Affiliations

Clinical Evidence 2030

Peter Arlett et al. Clin Pharmacol Ther. 2025 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests as defined by the American Society for Clinical Pharmacology and Therapeutics, or other interests that might be perceived to influence the results and/or discussion reported in this paper.

Figures

Figure 1
Figure 1
Representation of the vision for clinical evidence 2030.
See this image and copyright information in PMC

References

    1. European Commission . Proposal for a regulation of the European Parliament and of the Council on the European Health Data Space <https://eur‐lex.europa.eu/legal‐content/EN/TXT/?uri=CELEX:52022PC0197> (2022).
    1. European Commission . European Health Union: Commission proposes pharmaceuticals reform for more accessible, affordable and innovative medicines [Press release] <https://ec.europa.eu/commission/presscorner/detail/en/IP_23_1843> (2023).
    1. European Medicines Agency . Engagement framework: European Medicines Agency and patients, consumers and their organisations <https://www.ema.europa.eu/en/partners‐networks/patients‐consumers#framew...> (2022).
    1. Vamvakas, S. , Moseley, J. & Vetter, T. Multistakeholder advice at the European medicines agency: is it still needed? Clin. Pharmacol. Ther. 105, 819–821 (2019). - PubMed
    1. Hernán, M.A. & Robins, J.M. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758–764 (2016). - PMC - PubMed

LinkOut - more resources